A systematic review of pharmaceutical price mark-up practice and its implementation

Pharmaceutical products, apart from being essential for medical treatment, are of high value and heavily regulated to ensure the prices are controlled. This systematic review was conducted to identify pharmaceutical pricing mark-up control measures, specifically in the wholesale and retail sectors....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kah Seng Lee, Yaman Walid Kassab, Nur Akmar Taha, Zainol Akbar Zainal
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/5a89eeae26bc430f9cba0adf08329c02
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5a89eeae26bc430f9cba0adf08329c02
record_format dspace
spelling oai:doaj.org-article:5a89eeae26bc430f9cba0adf08329c022021-11-04T04:44:51ZA systematic review of pharmaceutical price mark-up practice and its implementation2667-276610.1016/j.rcsop.2021.100020https://doaj.org/article/5a89eeae26bc430f9cba0adf08329c022021-06-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667276621000202https://doaj.org/toc/2667-2766Pharmaceutical products, apart from being essential for medical treatment, are of high value and heavily regulated to ensure the prices are controlled. This systematic review was conducted to identify pharmaceutical pricing mark-up control measures, specifically in the wholesale and retail sectors. The search method comprised the following databases: PubMed, Science Direct, Springer Link, ProQuest, and EBSCOhost and Google Scholar. The results were filtered systematically from the inception of the aforementioned databases until 23 April 2021. Eligible studies were those focusing on the implementation of pharmaceutical pricing strategies that involve a) mark-ups of medicine, and b) pharmaceutical cost control measures. A total of 13 studies were included in this review: seven covered European countries, four covered Asian countries, one covered the USA and one covered Canada. The main points of discussion in the qualitative synthesis were the implementation of medicine mark-ups, price mark-up regulatory strategies and the outcomes of these regulatory strategies. Our findings suggest that Western countries have a lower mark-up margin, around 4% to 25% of the original purchased price, compared to Asian countries, up to 50%.Kah Seng LeeYaman Walid KassabNur Akmar TahaZainol Akbar ZainalElsevierarticlePrescription feesHealthcare costsDrug costsCost controlPharmaceutical economicsPrice listPharmacy and materia medicaRS1-441ENExploratory Research in Clinical and Social Pharmacy, Vol 2, Iss , Pp 100020- (2021)
institution DOAJ
collection DOAJ
language EN
topic Prescription fees
Healthcare costs
Drug costs
Cost control
Pharmaceutical economics
Price list
Pharmacy and materia medica
RS1-441
spellingShingle Prescription fees
Healthcare costs
Drug costs
Cost control
Pharmaceutical economics
Price list
Pharmacy and materia medica
RS1-441
Kah Seng Lee
Yaman Walid Kassab
Nur Akmar Taha
Zainol Akbar Zainal
A systematic review of pharmaceutical price mark-up practice and its implementation
description Pharmaceutical products, apart from being essential for medical treatment, are of high value and heavily regulated to ensure the prices are controlled. This systematic review was conducted to identify pharmaceutical pricing mark-up control measures, specifically in the wholesale and retail sectors. The search method comprised the following databases: PubMed, Science Direct, Springer Link, ProQuest, and EBSCOhost and Google Scholar. The results were filtered systematically from the inception of the aforementioned databases until 23 April 2021. Eligible studies were those focusing on the implementation of pharmaceutical pricing strategies that involve a) mark-ups of medicine, and b) pharmaceutical cost control measures. A total of 13 studies were included in this review: seven covered European countries, four covered Asian countries, one covered the USA and one covered Canada. The main points of discussion in the qualitative synthesis were the implementation of medicine mark-ups, price mark-up regulatory strategies and the outcomes of these regulatory strategies. Our findings suggest that Western countries have a lower mark-up margin, around 4% to 25% of the original purchased price, compared to Asian countries, up to 50%.
format article
author Kah Seng Lee
Yaman Walid Kassab
Nur Akmar Taha
Zainol Akbar Zainal
author_facet Kah Seng Lee
Yaman Walid Kassab
Nur Akmar Taha
Zainol Akbar Zainal
author_sort Kah Seng Lee
title A systematic review of pharmaceutical price mark-up practice and its implementation
title_short A systematic review of pharmaceutical price mark-up practice and its implementation
title_full A systematic review of pharmaceutical price mark-up practice and its implementation
title_fullStr A systematic review of pharmaceutical price mark-up practice and its implementation
title_full_unstemmed A systematic review of pharmaceutical price mark-up practice and its implementation
title_sort systematic review of pharmaceutical price mark-up practice and its implementation
publisher Elsevier
publishDate 2021
url https://doaj.org/article/5a89eeae26bc430f9cba0adf08329c02
work_keys_str_mv AT kahsenglee asystematicreviewofpharmaceuticalpricemarkuppracticeanditsimplementation
AT yamanwalidkassab asystematicreviewofpharmaceuticalpricemarkuppracticeanditsimplementation
AT nurakmartaha asystematicreviewofpharmaceuticalpricemarkuppracticeanditsimplementation
AT zainolakbarzainal asystematicreviewofpharmaceuticalpricemarkuppracticeanditsimplementation
AT kahsenglee systematicreviewofpharmaceuticalpricemarkuppracticeanditsimplementation
AT yamanwalidkassab systematicreviewofpharmaceuticalpricemarkuppracticeanditsimplementation
AT nurakmartaha systematicreviewofpharmaceuticalpricemarkuppracticeanditsimplementation
AT zainolakbarzainal systematicreviewofpharmaceuticalpricemarkuppracticeanditsimplementation
_version_ 1718445211620737024